Clinical Trial Update: To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ferroquine and artefenomel for uncomplicated Plasmodium falciparum malaria was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Infection

Drugs mentioned

• Artefenomel (artefenomel)
• Ferroquine (ferroquine)

Snippet

Sponsor: Sanofi | Conditions: Plasmodium Falciparum Infection | Phase 2 | Status: TERMINATED | Results posted: 2020-10-19